 "Claris Lifesciences dips on disappointing Q4 results")
Claris Lifesciences has dipped nearly 7% to Rs 156 on the BSE in an otherwise firm market after the company reported 60% year on year (YoY) decline in consolidated net profit of Rs 4 crore for the quarter ended March 31, 2016 (Q4FY16). The pharmaceutical company posted a profit of Rs 13 crore in an year ago quarter.
Net income increased 6% at Rs 168 crore on YoY basis. The company said, the January to March quarter has traditionally been the leanest quarter.
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin reduced to 21% in Q4FY16 from 24% in the previous year quarter due to expansion of management overheads and absorption of CL2 fixed overheads.
At 12:34 PM, the stock was down 6% at Rs 158 as compared to 1.4% gain in the S&P BSE Sensex. Around 84,000 shares changed hands so far against an average 64,000 shares that were traded daily in past two weeks on the BSE.
Net income increased 6% at Rs 168 crore on YoY basis. The company said, the January to March quarter has traditionally been the leanest quarter.
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin reduced to 21% in Q4FY16 from 24% in the previous year quarter due to expansion of management overheads and absorption of CL2 fixed overheads.
At 12:34 PM, the stock was down 6% at Rs 158 as compared to 1.4% gain in the S&P BSE Sensex. Around 84,000 shares changed hands so far against an average 64,000 shares that were traded daily in past two weeks on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%